Literature DB >> 26982715

Clonal expansion of Escherichia coli ST38 carrying a chromosomally integrated OXA-48 carbapenemase gene.

Jane F Turton1, Michel Doumith1, Katie L Hopkins1, Claire Perry1, Daniele Meunier1, Neil Woodford1.   

Abstract

Many isolates of Escherichia coli carrying blaOXA-48 referred to Public Health England's national reference laboratory during 2014 and 2015 shared similar pulsed-field gel electrophoresis (PFGE) profiles, despite coming from patients in multiple different hospitals and regions. Whole genome sequencing on an Illumina platform revealed that these belonged to sequence type (ST) 38. The OXA-48 gene is usually carried on a 62 kb IncL/M plasmid (pOXA48a), but those belonging to this ST appeared either to lack plasmid elements or to have only a partial complement. Two isolates, one belonging to a main cluster sharing identical PFGE profiles and the other having a distinct profile, were further sequenced on a minION. The long reads provided by the nanopore sequencing technology facilitated assembly of a much larger contig around the blaOXA-48 region, showing that both isolates shared a similar arrangement, with a plasmid fragment containing blaOXA-48 flanked by IS1R elements integrated into the chromosome, although the length of the plasmid fragment and the insertion site differed between the two isolates. That belonging to the main cluster contained a 21.9 kb Tn6237 insert, as previously described in E. coli EC-15 from Lebanon, but in a different insertion site. PCR mapping indicated that a further 14/31 representatives of this cluster also contained this insert in the same insertion site, with most of the remainder differing only by having additional E. coli sequence on one side of the insertion. This sub-cluster of ST38 was found from 25 different hospital laboratories, suggesting widespread distribution of a successful type.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26982715     DOI: 10.1099/jmm.0.000248

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  26 in total

1.  Genomic Characterization of Carbapenemase-Producing Klebsiella pneumoniae with Chromosomally Carried bla NDM-1.

Authors:  Noriko Sakamoto; Yukihiro Akeda; Yo Sugawara; Dan Takeuchi; Daisuke Motooka; Norihisa Yamamoto; Warawut Laolerd; Pitak Santanirand; Shigeyuki Hamada
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

2.  Repeated Detection of Carbapenemase-Producing Escherichia coli in Gulls Inhabiting Alaska.

Authors:  Christina A Ahlstrom; Andrew M Ramey; Hanna Woksepp; Jonas Bonnedahl
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

3.  Molecular Characterization of OXA-48-Like-Producing Enterobacteriaceae in the Czech Republic and Evidence for Horizontal Transfer of pOXA-48-Like Plasmids.

Authors:  Anna Skalova; Katerina Chudejova; Veronika Rotova; Matej Medvecky; Vendula Studentova; Eva Chudackova; Pavel Lavicka; Tamara Bergerova; Vladislav Jakubu; Helena Zemlickova; Costas C Papagiannitsis; Jaroslav Hrabak
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

Review 4.  The Global Ascendency of OXA-48-Type Carbapenemases.

Authors:  Johann D D Pitout; Gisele Peirano; Marleen M Kock; Kathy-Anne Strydom; Yasufumi Matsumura
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

Review 5.  Clinical Implications of Genomic Adaptation and Evolution of Carbapenem-Resistant Klebsiella pneumoniae.

Authors:  Angela Gomez-Simmonds; Anne-Catrin Uhlemann
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

Review 6.  OXA-48-like carbapenemases producing Enterobacteriaceae in different niches.

Authors:  Assia Mairi; Alix Pantel; Albert Sotto; Jean-Philippe Lavigne; Aziz Touati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-08       Impact factor: 3.267

7.  OXA-244-Producing Escherichia coli Isolates, a Challenge for Clinical Microbiology Laboratories.

Authors:  Yannick Hoyos-Mallecot; Thierry Naas; Rémy A Bonnin; Rafael Patino; Philippe Glaser; Nicolas Fortineau; Laurent Dortet
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

8.  In Vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from 2012 to 2015.

Authors:  Krystyna M Kazmierczak; Patricia A Bradford; Gregory G Stone; Boudewijn L M de Jonge; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

Review 9.  Treatment of Infections by OXA-48-Producing Enterobacteriaceae.

Authors:  Adam Stewart; Patrick Harris; Andrew Henderson; David Paterson
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

10.  bla OXA-48-like genome architecture among carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the Netherlands.

Authors:  Antoni P A Hendrickx; Fabian Landman; Angela de Haan; Sandra Witteveen; Marga G van Santen-Verheuvel; Leo M Schouls
Journal:  Microb Genom       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.